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Abstract
Introduction: Stroke is a major cause of death and disability. Accurately predicting stroke outcome from a set of predictive
variables may identify high-risk patients and guide treatment approaches, leading to decreased morbidity. Logistic
regression models allow for the identification and validation of predictive variables. However, advanced machine learning
algorithms offer an alternative, in particular, for large-scale multi-institutional data, with the advantage of easily
incorporating newly available data to improve prediction performance. Our aim was to design and compare different
machine learning methods, capable of predicting the outcome of endovascular intervention in acute anterior circulation
ischaemic stroke.
Method: We conducted a retrospective study of a prospectively collected database of acute ischaemic stroke treated by
endovascular intervention. Using SPSSH, MATLABH, and RapidminerH, classical statistics as well as artificial neural network
and support vector algorithms were applied to design a supervised machine capable of classifying these predictors into
potential good and poor outcomes. These algorithms were trained, validated and tested using randomly divided data.
Results: We included 107 consecutive acute anterior circulation ischaemic stroke patients treated by endovascular
technique. Sixty-six were male and the mean age of 65.3. All the available demographic, procedural and clinical factors were
included into the models. The final confusion matrix of the neural network, demonstrated an overall congruency of ,80%
between the target and output classes, with favourable receiving operative characteristics. However, after optimisation, the
support vector machine had a relatively better performance, with a root mean squared error of 2.064 (SD: 60.408).
Discussion: We showed promising accuracy of outcome prediction, using supervised machine learning algorithms, with
potential for incorporation of larger multicenter datasets, likely further improving prediction. Finally, we propose that a
robust machine learning system can potentially optimise the selection process for endovascular versus medical treatment in
the management of acute stroke.
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Introduction
Stroke and Endovascular Treatment
Stroke is a major global public health issue and is considered the
third most costly health condition in developed countries [1].
Approximately 800,000 cases of stroke are reported in United
States of America per annum, leading to 200,000 deaths, almost
one of every 16 deaths [2,3]. For those who survive, it is the most
common cause of adult disability in the modern world [2,4],
requiring expensive long term rehabilitation care[2,5–7] amount-
ing to costs estimated at over 60 billion dollars per year in the
United States of America alone [2,5,8]. More than 80% of stroke
cases are ischaemic, with the remainder being haemorrhagic [2].
Urgent reperfusion of the ischemic brain is the primary
treatment aim, either by intravenous thrombolysis or by endovas-
cular interventional techniques [9]. These treatments focus on
vascular recanalisation and restoration of blood flow to the
ischemic tissue [10]. Although there are varying estimates to the
potential number of patients who may benefit from endovascular
intervention, there will likely be expansion of the number of
patients treated using these techniques [2,11,12].
Initial focus was on intraarterial thrombolysis, proposed to be
safe up to 6 hours post ictus in Pro-Urokinase for Acute Cerebral
Thromboembolism II (PROACT-II) trial [1,13]; however, rapid
mechanical clot extraction with decreased time to cerebral
reperfusion has obvious appeal and in fact is theoretically ideal
for platelet poor, fibrin rich, well organized cardiogenic emboli,
refractory to mechanical lysis2. Therefore, subsequent develop-
ments of various mechanical thrombectomy devices has gained
much interest with the theoretical advantage of faster recanalisa-
tion and potential lower rate of hemorrhagic transformation;
possibly leading to an extended time window in stroke intervention
[1].
FDA approval for MERCI Retrieval and Penumbra Stroke
Systems[2,14–19] as the first generation of mechanical thrombec-
tomy devices was followed by introduction of Solitaire and Trevo
as stent retrievers [10]. Introduction of these devices backed up by
the pioneering studies MERCI, multi-MERCI, and Penumbra, as
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well as Pivotal and SWIFT, have further strengthened the
importance of the mechanical techniques in large vessels
occlusion[10,20–26]. However, despite more than 80% recanali-
sation success, randomised controlled trials such as Interventional
Management of Stroke (IMS) - III [1,27], have still failed to show a
significant improvement in the clinical outcome, evaluated by 90
day modified Rankin Scale score[2,10,22,28–33].
The SYNTHESIS trial also failed to show any superiority of
endovascular intervention or even for combined endovascular and
peripheral thrombolysis over traditional intravenous tPA[34–36].
This conundrum was made more complicated when the MR-
RESCUE trial demonstrated not only that embolectomy was no
better than standard care, but also a favorable penumbral pattern
on imaging does not necessarily indicates patients who would
benefit from endovascular therapy [37].
This discrepancy between the IMS-III, SYNTHESIS and MR-
RESCUE outcomes and what may have been intuitively expected
is likely related to the multiple potential pitfalls in the design of
these trials which could change the interpretation of the results
[1,38,39]. The most commonly speculated factor is that patient
selection was neither targeted to those who failed IV thrombolysis,
nor to those with large vessel occlusion or large clot burden $
8 mm, who are usually not responsive to chemical treatment
alone; as no vascular imaging was required prior to inclusion into
the studies[1,38–40]. These limitations could certainly influence
the accuracy of the studies in evaluation of the clot retrieval
techniques. On the other hand, stentretrievers, now acknowledged
as more effective devices, were included only very late into the
studies like IMS-III, with less than 1% of cases treated using
Solitaire. Since the release of these preliminary results at least six
additional devices have started premarket testing[1,38–40].
It appears that the situation is different for posterior circulation
involvement. Although causing only 6–10% of large vessel strokes,
posterior circulation occlusions have a relatively different course,
and failure of recanalisation, in particular in comatose patients or
those with basilar trunk involvement results in a very poor
prognosis [2,41]. The BASICS (Basilar Artery International
Cooperation Study) did not show a definite superiority for
intraarterial intervention over intravenous thrombolysis [2,42];
and the overall outcome is quite variable in patients who are
treated with intraarterial or intravenous thrombolysis, in particular
depending on the therapeutic delay [2,43]. On the other hand,
some trials have already demonstrate more than 50% recanalisa-
tion success rate for intraarterial techniques, with relatively good
outcome [2,44].
However, randomized control trials are restricted and limited
by the lower incidence of posterior circulation strokes, and the
results are potentially influenced by the heterogeneity of both the
presentations and the causes; and at this stage the rational for
aggressive treatment is mainly based on anecdotal evidence
[2,22,23,45].
Overall the major obstacle in endovascular intervention of the
ischemic stroke is to establish a set of criteria identifying those
patients who may benefit from intervention, whilst avoiding
potential unwanted catastrophic treatment related complications.
There is currently level I evidence that NIHSS (National
Institute of Health Stroke Score) [46,47] is a quick and relatively
simple guide to estimate the extent and the severity of a stroke, and
probably correlates with the clinical outcome [46]. It is however,
unable to measure the size of established infarction, separate from
the salvageable parenchyma, and is therefore unable to predict
potential outcome after endovascular intervention accurately. This
is consistent with the well known fact that multiple factors
contribute to and influence recanalisation success, including the
extent and site of the vascular occlusion; and that the overall
outcome also depends on patient demographic factors as well as
clinical setting such as the time from onset, duration and the
severity of the presenting neurological insult [10].
The complexity of the all of these factors involved, makes
prediction of the final outcome difficult. On the other hand,
undoubtedly, accurately predicting the outcome from a set of
predictive variables is an important aspect of clinical work, which
can assist in identifying high-risk patients and guide treatment
approaches, thus potentially decreasing morbidity and mortality.
Such a model in prediction of the outcome, not only may be
crucial in prognostication, but can also have future roles in patient
selection for the variety of the treatment options available and the
relevant studies.
Prognostic Modeling and Machine Learning
The usual approach to analyse the stroke outcomes data is to
develop logistic regression models; however, machine learning
algorithms have been proposed as an alternative, in particular for
large-scale multi-institutional data, with the advantage of easily
incorporating newly available data to improve prediction perfor-
mance [48,49].
Machine Learning algorithms can be applied and its trained,
under two major different scenarios; supervised and unsupervised.
In supervised scenario the predicted outputs are known and used
to train the models. In unsupervised machines, the desired output
Table 1. Demographics and gender ratio.
Age and gender distribution of the patients:
Age Gender
Mean 65.3 Female 41
Median 67 Male 66
Mode 80
Std. Deviation 13.8
Minimum 23
Maximum 90
doi:10.1371/journal.pone.0088225.t001
Table 2. Distribution of the occluded vessels.
Occluded Arteries:
Artery Occlusion
1st 2nd 3rd
ACA 0 2 1
MCA- M1 55 21 0
MCA- M2 14 9 2
MCA- M3 1 1 0
MCA/ICA 1 0 0
ICA- Proximal 1 0 0
ICA- Intracranial/distal 22 2 0
ICA- extracranial 11 1 0
ICA- Terminal 1 0 0
CCA 2 0 0
doi:10.1371/journal.pone.0088225.t002
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is unknown, and the objective is to discover structure in the data,
not to generalise a mapping from inputs to outputs [49,50].
Two of the most commonly used machine learning methods
include artificial neural network and support vector machine.
These models are trained supervised, with neural network
algorithms capable of unsupervised training as well [48,49].
Although the technical details of theses algorithms are beyond
the scope of this article, a summary of them follows:
Artificial neural network is a mathematical and computational
model that is inspired by the structure and functional aspects of
biological neural systems [49,50]. It consists of interconnected
nodes, processing information using a connectionist computational
approach. The central connectionist principle proposes that
complex neurological and mental phenomena can be described
by an interconnected network of simple uniform units [50],
adaptively changing their structure based on external or internal
information, which flows during the learning phase, forming a
robust dynamic system modelling the complex relationships
between inputs and outputs or patterns in data[49–51].
From the different topological types of neural networks, the
commonly used feed-forward is a network where connections
between the units do not form a directed cycle or loop, and the
information moves in only one direction, forward, from the input
nodes, through the hidden nodes to the output nodes [50]. Back
propagation algorithm is a supervised learning method divided
into propagation and weight update phases, which are repeated
until the performance of the network is good enough, while the
output values are compared with the correct answer to compute
the value of some predefined error-function [49,50]. This
calculated error is then fed back through the network, adjusting
the weights of each connection accordingly, in order to reduce the
error function [50]. Repeating this process usually eventually
converges to some state where the error of the calculations is
minimised, at which point the network is considered trained for a
certain target function [49].
In comparison to the artificial neural network, the support
vector machine works very differently. It takes a set of input data
and predicts which of the different possible classes comprises the
input, making it a non-probabilistic linear classifier. A set of
training data is given and marked as belonging to one of the
categories. An SVM training algorithm builds a model that assigns
new data into one category or the other.
The example data points are initially mapped as points in space,
Table 3. ICH classification.
Classification of Infarction Haemorrhagic Transformation
Type Name Definition
Asymptomatic HI-1 Haemorrhagic infarction type 1 Small petechiae along the margins of the infarct
HI-2 Haemorrhagic infarction type 2 More confluent petechiae within the infarcted area but without
space-occupying effect
PH-1 Parenchymal haemorrhage type 1 Haematoma in #30% of the infarcted area with some slight
space-occupying effect
PH-2 Parenchymal haemorrhage type 2 Dense haematoma in .30% of the infarcted area with substantial
space-occupying effect or as any haemorrhagic lesion
outside the infarcted area.
Symptomatic Symptomatic intracranial haemorrhage parenchymal haemorrhage type 2 (PH-2) with
neurological deficit
Others IVH Interventricular Haemorrhage
SAH Subarachnoid Haemorrhage
doi:10.1371/journal.pone.0088225.t003
Table 4. Haemorrhagic Transformation.
Type No.
Asymptomatic HI-1 4
HI-2 16
PH-1 1
PH-2 5
Symptomatic 5
Others IVH 0
SAH 0
doi:10.1371/journal.pone.0088225.t004
Figure 1. 90 days mRS histogram.
doi:10.1371/journal.pone.0088225.g001
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so that the examples of the separate categories are divided by a
clear gap that is as wide as possible, and then unknown data is
represented in that same space, and predicted to belong to a
category based on which side of the gap they fall on[49–51]. In
doing so, the algorithm constructs a hyperplane or a set of
hyperplane in an infinite-dimensional space, which can be used for
classification, regression, or other tasks. Intuitively, a good
separation is achieved by the hyperplane that has the largest
distance to the nearest training data points of any class[49–51].
This gap is called functional margin, and in general the larger the
margin the lower the generalisation error of the classifier[49–51].
Whereas the original problem may be stated in a finite
dimensional space, it often happens that the sets to discriminate
are not linearly separable in that space. For this reason, it was
proposed that the original finite-dimensional space be mapped
into a much higher-dimensional space, presumably making the
separation easier in that space[49–51]. To keep the computational
load reasonable, the mapping is designed to ensure that dot
products may be computed easily in terms of the variables in the
original space, by defining them in terms of a kernel function
K(x,y) selected to suit the problem. The hyperplanes in the higher
dimensional space are defined as the set of points whose inner
product with a vector in that space is constant[49–51].
Our Study
We aimed to design a prognostic model for the endovascular
intervention in acute ischemic stroke using machine learning
algorithms. We compared and assessed these two advanced
methods in terms of their capability in predicting outcome.
We decided to separate anterior and posterior circulation
strokes and model them independently to avoid potential
inadvertent underlying inhomogeneities.
Methods
This is a retrospective study on a prospectively collected completely de-
identified clinical database, which received approval from the ethics committee
at our institution, and our review board has waived the need for consent
(HREC: QA2011100). The technical details is provided below to facilitate
reproducibility for other datasets if available.
Demographics and clinical details of 107 patients who presented
with acute anterior or posterior circulation stroke to our institution
who underwent endovascular treatment, over a period of
approximately five years, were extracted from a prospectively
maintained stroke database (Table 1).
Patients were all screened for relevant comorbidities at the time
of presentation, including: diabetes mellitus, hypertension, hyper-
cholesterolaemia, atrial fibrillation, history of ischemic heart
disease and previous cerebral stroke or transient ischaemic attack.
Neurological examination was performed for all of the patient
prior to any intervention and the baseline National Institute of
Health Stroke Scores were recorded in the database.
From the initial diagnostic angiogram occluded vessels were
identified (Table 2). In the case of multiple sequential occlusions,
the proximal vessel was used as a data point, and depending on the
extent and segments involved, the artery was categorised as first,
second and third occlusion.
Some of the patients also had IV-tPA prior to endovascular
intervention. Different endovascular recanalisation devices were
used, including Solitaire stent retriever, MERCI and Penumbra
devices.
In addition to mechanical thrombectomy, some cases also
received intraarterial chemical thrombolytic agents; and if present,
associated or post-recanalisation hemodynamically significant
stenoses were also treated with angioplasty or stent insertion.
After treatment of the occluded artery(s), recanalisation success
was scaled using Thrombolysis in Cerebral Infarction (TICI)
Score, by the blinded consensus of the treating neurointervention-
alists. TICI score in conjunction with the number of attempts for
recanalisation, procedure duration, and time of onset to recana-
lisation, as well as patient general anesthesia status, were all
recorded into the database.
All procedural or delayed post-procedural complications were
also recorded, including: arterial perforation and puncture site
haematoma or pseudoaneurysm.
Post-procedure CT scans of the brain at 24–36 h were all
assessed by neuroradiologist and neurointerventionists assessing
for the presence of acute stroke and intracranial haemorrhage.
Intracranial haemorrhagic transformations, were divided into
clinically silent or symptomatic, and then classified into different
categories (Table 3).
Procedural outcome was monitored with modified Rankin
Score, measured 90 days after onset. A final dichotomised good
Figure 2. Relative importance of the model’s variables in
prediction of mRS at 90 days (outcome).
doi:10.1371/journal.pone.0088225.g002
Figure 3. Comparison between predicted and observed
outcome.
doi:10.1371/journal.pone.0088225.g003
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and bad outcome was also recorded for the patients as per mRS,
with less than or equal 2 considered as good.
First, using SPSSH (IBM Corporation), a Standard Linear
Model was designed, using Forward-Stepwise as the model
selection method, and Information Criterion (AICC) as the
criteria for entry. Potential predictors of the mRS as the outcome
measure was identified and a prediction model was formed and
compared with the observed outcome for validation.
Supervised machine learning was then attempted. Initially using
MATLABH (MathWorks Inc.) and its Neural Network Toolbox, a
two-layer Feed-Forward network with sigmoid hidden and linear
output neurons, was designed.
Figure 4. Network performance, for seven scale (left/top) and dichotomised mRS models (right/bottom). Legend: Blue-Training, Green-
Validation, Red-Test, Dashed Lines-Best, Vertical Axis-MSE, Horizontal Axis-Epochs.
doi:10.1371/journal.pone.0088225.g004
Table 5. 90 days mRS.
Modified Rankin Score (mRS)
Mean 2.57
Median 2
Mode 0
Std. Deviation 2.21
Minimum 0
Maximum 6
doi:10.1371/journal.pone.0088225.t005
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The data was then randomly divided into 70, 15 and 15
percents subsets and the network was trained using Levenberg-
Marquardt algorithm, validated and tested using the modified
Rankin score as outcome; with the performance of the model
monitored using Mean Squared Error. Prediction errors were also
depicted on a histogram.
In addition, for comparison, the network was also trained using
the dichotomised mRS, .2 or #2, to evaluate a binary classifier
for potential good and poor outcomes.
For the seven scale mRS network, linear regressions were also
performed between the observed and estimated outcome, over the
training, validation and test datasets independently using Theil–
Sen estimator.
However, with the dichotomised model being a binary classifier,
Receiver Operating Characteristic curves were calculated to
illustrate the performance of the system over each dataset as its
discrimination threshold is varied. In addition, confusion matrices
or contingency tables were also calculated, allowing better
representation of the performance of the network.
The designed network and its calculated weighting matrix was
then saved to be imported into the Simulink Toolbox of
MATLABH (MathWorks Inc.) for outcome prediction of the
future data.
Subsequently to assess the capabilities of other supervised
machine learning systems, the dataset with scaled and dichot-
omised mRS were imported into the data-mining program,
RapidminerH (Rapid-I Inc.). The filtered data was then given to
the input training port of a nested cross-validation operand, with
the relative number of validation of 10% and a shuffled sampling
type, as well as ‘‘Leave One Out’’.
The cross-validation operand consisted of two components,
training and testing. The testing component contained a Support
Vector Machine, with ANOVA Kernel, which is defined by raised
to power ‘‘d’’ of summation of ‘‘exp(2g (x–y))’’ where ‘‘g’’ is
gamma and ‘‘d’’ is the degree. ‘‘g’’ and ‘‘d’’ were set to be 1 and 2
in our machine.
The size of the cache for kernel evaluations was set to be 200
megabytes. The complexity constant (‘‘C’’) which sets the
tolerance for misclassification, was set to be zero. The convergence
Figure 5. Error Histogram, for seven scale (left/top) and dichotomised mRS models (right/bottom). Legend: Blue-Training, Green-
Validation, Red-Test, Orange Line-Zero Error, Vertical Axis-Instances, Horizontal Axis-Error.
doi:10.1371/journal.pone.0088225.g005
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epsilon, which is an optimizer parameter specifying the iterations
stop point, was set to 0.001, with maximum iteration set to be
100000. In our machine, the loss function positive and negative
complexity constant was set to 1.0. The insensitivity constant,
epsilon as well as the epsilon for positive and negative deviations,
were all set to be zero.
The model calculated in this machine is passed onto the testing
component of the parent x-validation operand and then applied
on to the test dataset.
The performance of the machine was monitored by a classic
performance monitor operand and was reported as the mean
squared error as well as its root. In addition, accuracy of the
machine was also assessed by aggregation of a hidden confusion
matrix constructed by evaluating different models on different test
sets.
The designed model is finally incorporated into an apply
operand ready for the prediction of the outcome of the future
patients.
Results
Average of the patients’ baseline stroke score was 17.7 (SD:
67.9).
44 of our patients also had IV-tPA prior to endovascular
intervention. The remainder of the patients did not receive tPA
due to a variety of contraindications.
81% of the procedures were performed under generalized
anesthesia, and our three neurointerventionalists (BY, PJM and
RJD) performed 24, 48, 35 cases respectively, as the primary
operator.
Solitaire stent retriever was used in the majority of the cases 73,
MERCI and Penumbra devices were used in 17 and 2 cases
respectively. In some cases instrumentation was repeated up to 6
times to improve recanalisation.
2 cases received urokinase, 4 tissue plasmin activator, and 4
plasmin, as adjunct intraarterial chemical thrombolytic agents.
Overall recanalisation has been very successful with TICI 2b or
3 demonstrated on the final angiographic run in approximately
50% of cases. Significant associated and post-recanalisation
arterial stenosis was also noted in some cases, with 23 patients
requiring angioplasty, with 10 patients eventually stented.
On average procedures have taken 82.3 minutes (SD: 639.0).
The time of onset to recanalisation was on average 339.7 minutes
(SD: 691.8).
Immediate procedural complications including arterial perfora-
tion or puncture site haematoma and pseudoaneurysm were
uncommon, only seen in 1 and 2 cases respectively.
31 patients were diagnosed with intracranial haemorrhage on
the delayed post procedural CT, with a wide spectrum of locations
and severities, from subarachnoid hemorrhage to asymptomatic or
large intra-parenchymal bleedings (Table 4).
The average of mRS at 90 days was 2.57 (SD: 62.21), with
median of 2 and mode of 0 (Figure 1 & Table 5).
Figure 6. Linear fit between the estimated and observed outcome.
doi:10.1371/journal.pone.0088225.g006
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Standard Modelling
The information criterion and accuracy of the proposed linear
model were calculated as 119.67 and 43.5% respectively (Figure 2).
The most influential predictor was baseline NIHSS, with relative
predictive value of 0.4 (Figure 3).
Artificial Neural Network
The best validation performance was 6.94 and 2.98, at epoch 6
and 5 for seven scale and dichotomised mRS models respectively
(Figure 4).
Gradient of 1.30561027 and 3.03861021 were calculated at
epoch 12 and 11 for seven scale and dichotomised mRS models
respectively.
Error histograms were calculated as the difference between the
target and output which are equivalent of observed and estimated
outcome, from the training, test and validation datasets, for seven
scale and dichotomised mRS models (Figure 5).
Using Theil–Sen estimator, the root of the Coefficient of
Determination calculated as 0.95, 0.47 and 0.32 for each subset
respectively. However, overall network estimated and observed
outcome for the whole dataset, demonstrate a relatively good
linear correlation with an R of 0.79 in a linear regression (Figure 6).
Overall, favourable ROC curves; however, the test ROC curve
is relatively poor, with the estimated area under curve (AUC) of
0.6.
The contingency table, with each column representing the
instances of the predicted outcome and each row demonstrating
the observed outcome, confirming acceptable model sensitivity
and specify (Figure 7).
Support Vector Machine
For the scaled mRS outcome, our support vector machine, had
a good performance with a mean squared error of 4.489 (SD:
62.438) and the estimated root at 2.064 (SD: 60.480). Also, the
system accuracy was assessed by ‘‘mikro’’, calculated as 2.128.
On the other hand, system’s MSE and ‘‘mikro’’ were calculated
as 0.262 (SD: 60.068), and 0.514, respectively in prediction of the
dichotomised outcome, with the precision of 80% in prediction of
the poor outcome and an overall precision of 87% and model
accuracy of approximately 70% (Table 6).
Best performance of the scaled mRS model was in prediction of
the patients’ prognosis with mRS of 3, with a class precision of
Figure 7. Over all ROC curve and Confusion Matrix for the dichotomised outcome network.
doi:10.1371/journal.pone.0088225.g007
Table 6. Model precision of support vector machine in
prediction of the dichotomised intervention outcome.
Outcome True Poor True Good Class Precision
Predicted Poor 27 7 79.41%
Predicted Good 26 47 64.38%
Class Recall 50.94% 87.04% 87.04%
doi:10.1371/journal.pone.0088225.t006
Machine Learning in Stroke Treatment
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100% and the least precise prediction was for those patient with
mRS of 6, which was only approximately 25%.
Estimated machine’s performance was improved even further
when the cross validation operand set to work with ‘‘Leave Out
One’’ sampling rather than ‘‘Shuffled’’, with a MSE of 4.347 (SD:
64.425) and rMSE of 1.809 (SD: 61.037) for the scaled mRS
outcome, and 0.286 (SD: 60.367) and rMSE of 0.441 (SD:
60.302) for the for the dichotomised model.
The ‘‘mikro’’ indicator of accuracy, was calculated as 2.085 and
0.535, with the ‘‘Leave Out One’’ sampling for the scaled mRS
and dichotomised outcome predictor machines, respectively.
Conclusions
We showed, despite a small dataset, that there was promising
accuracy, approaching 70%, of predicting outcome. There is the
likely potential of further improving prediction by the incorpora-
tion of larger multicenter datasets.
There has been recent interest in adopting machine learning
techniques in the prediction of the outcome of stroke patients. A
recent study proposed spatial regularisation of the diffusion-
weighted images acquired at the acute stage using support vector
machine with a Graph encoding the voxels’ proximity, and
concluded significant accuracy in prediction of the motor outcome
at 90 days, showing that poor motor outcome is associated with
the changes in the corticospinal bundle and white matter tracts
originating from the premotor cortex [52].
Another study has proposed use of machine learning in
individualised stroke treatment decision making by accurate
identification of the extent of salvageable tissue on MRI in rats,
based on measurement of a perfusion-diffusion mismatch and
calculation of infarction probability. This study has compared
generalized linear model (GLM), generalized additive model,
support vector machine, adaptive boosting, and random forest;
proposing that assessment of the heterogeneity of infarction
probability with imaging based algorithms enables estimation of
the extent of potentially salvageable tissue after acute ischemic
stroke [53].
Conversely, attempts to prove the effectiveness of the invasive
stroke treatments have shown inconsistent results. However, more
than ever before, endovascular treatments of acute ischemic stroke
are opening their way into the mainstream management of the
acute stroke, in particular for those patient with contraindication
for IV thrombolysis or large vessel occlusions[10,54–58].
To our knowledge there is no comprehensive multifactorial
study in humans, attempting to apply machine learning algorithms
in acute ischemic stroke outcome prediction, after invasive
endovascular management. Undoubtedly numerous factors, in-
cluding extensive clinical features, can influence the final stroke
outcome with varying significance and mechanisms, making
conventional modelling challenging and perhaps inaccurate.
Machine learning models however, being, relatively indepen-
dent of the unknown potential underlying interactions between
these factors, are probably able to simulate the eventual result of
such a complex system.
Such models can be of extreme use not only for prognostication
and in predicting the outcome under different circumstances, but
also in near future as an assistant in clinical decision making in
particular identifying those patients who may benefit from a
variety of possible treatment options, including more aggressive
management, like endovascular interventions.
Limitations
Parallel to the all abovementioned advantages of the machine
learning algorithms, there are important underlying assumptions
and limitations that should not be forgotten. These models
although can be accurate, and perhaps useful in answering the
Figure 8. Ultimate goal is to design a system capable of proposing a dichotomised outcome for each patient with and without
endovascular intervention.
doi:10.1371/journal.pone.0088225.g008
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primary question, but more or less behave as a ‘‘black box’’
requiring large training datasets to improve their performance,
with the true underlying relationships between influential factors
remaining undiscovered to the user [48,49,51].
This inherent need for large training datasets may affect the
accuracy of the machines in studies, like the current study, when
only representative training data is used. In addition, with no clear
understanding of the true predictors, an overcorrected conserva-
tive design may lead to the models being over-fitted by irrelevant
demographics or clinical factors, thus increasing the random error
and covering the desired signal with noise, a phenomenon which
may explain the poor ROC curve for the test group, in this study.
To avoid this, techniques like cross-validation, regularization,
pruning or Bayesian model comparison, can be used to indicate
the tipping point when further training no longer results in a better
performance; or alternatively decision tree learning methods can
be employed, providing more interpretable models [48,49,51].
Future Work
All of the underlying methodological and computational
complexities aside, our long term goal is to design an easy to use
online system, allowing for relative prediction of the clinical
outcome based on the demographics and clinical findings, which
can be used as a guide in making appropriate therapeutic decisions
(Figure 8).
Such a system has the potential for fine adjustment from the
continuous training provided via handling large-scale national or
international multi-institutional users, with the advantage of easily
incorporating newly available data to improve prediction perfor-
mance.
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